BlossomHill Therapeutics, Inc. (BLSM)

NASDAQ

$17,43

$+0,61

(+3,61%)

Pre-Market

BlossomHill Therapeutics, Inc. (BLSM) Live Price Chart

Last updated: ⁦2026-10-12 08:55:20⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

BlossomHill Therapeutics, Inc. (BLSM) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $17,43, with a market capitalisation of $555,60M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $15,25 to $27,99. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$555,60M
Open	$16,80
Day's High	$27,99
Day's Low	$15,25
Previous Close	$16,88
Volume	121,81K
Average Volume	258,37K
P/E Ratio	--
52-Week High	$27,99
52-Week Low	$15,25
Dividend Yield	--
Earnings Date	--

BlossomHill Therapeutics, Inc. (BLSM) Pre-Market Stock Price

BlossomHill Therapeutics, Inc. (BLSM) is trading at $17,10 in pre-market trading as of 2026-10-09 23:42:00, up 1,27% ($0,21) from the previous close of $16,88

Pre-market trading shows how investors are pricing BLSM before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

BlossomHill Therapeutics, Inc. (BLSM) 7-Day Stock Price Change

Over the past seven days, BlossomHill Therapeutics, Inc. (BLSM) moved from $18,59 to $17,43, representing a decline of 6,27% ($1,16).

The stock traded between $16,12 and $20,11 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 188,80 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

BLSM 52-Week Price Position

Position in Range: 17,1%

52W Low$15,25

52W High$27,99

BLSM is currently trading at $17,43, placing it 17,1% of the way from its 52-week low of $15,25 to its 52-week high of $27,99. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is BlossomHill Therapeutics, Inc. (BLSM)?

BlossomHill Therapeutics Inc is a clinical-stage biopharmaceutical company applying its intentional, chemistry-based approach to develop small molecule medicines that address unmet medical needs in cancer treatment. Its product pipeline includes two clinical-stage programs: BH-30643, an investigational, non-covalent, macrocyclic, brain active, mutant-selective OMNI-EGFR inhibitor for the treatment of epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC), and BH-30236, an investigational macrocyclic CDC-like kinase (CLK) inhibitor being evaluated first in relapsed or refractory acute myeloid leukemia (R/R AML) and higher-risk myelodysplastic syndromes (HR-MDS), and the preclinical-stage product candidate BH-501284 targeting activated KRAS.

BlossomHill Therapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	69
Exchange	NASDAQ
Company Website	https://www.bhtherapeutics.com

How to Buy BlossomHill Therapeutics, Inc. (BLSM) Stock on MEXC

Eligible investors can buy real shares of BlossomHill Therapeutics, Inc. (BLSM) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for BLSM and Place Your Order

Open the RealStocks trading page and search for BLSM. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is BlossomHill Therapeutics, Inc. (BLSM) share price today?

BlossomHill Therapeutics, Inc. (BLSM) is currently trading at $ 17,43, up 3,23% ($0,55) from the previous close of $ 16,88. Intraday prices update in real time during regular trading hours.

2.Is BLSM stock going up or down today?

As of 2026-10-09 23:42:00, BLSM is trading at $ 17,43, up 3,23% ($0,55) from its previous close of $ 16,88. The stock has traded between $ 15,25 and $ 27,99 during today’s regular session. Past price movements do not guarantee future results.

3.What is BLSM pre-market price?

As of 2026-10-09 23:42:00, BLSM is trading at $ 17,10 in pre-market trading, up 1,27% ($0,21) from the previous close of $ 16,88. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is BLSM after-hours price?

As of 2026-10-09 23:42:00, BLSM is trading at $ 17,53 in after-hours trading, up 3,85% ($0,65) from the regular-session close of $ 16,88. After-hours prices may differ from the regular session's opening price due to lower liquidity and wider bid-ask spreads.

5.Is BLSM stock trading now?

BLSM trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does BLSM sit relative to its 52-week high and low?

Over the past 52 weeks, BLSM has traded between a low of $ 15,25 and a high of $ 27,99. At $ 17,43, the stock is positioned 17,1% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is BlossomHill Therapeutics, Inc. in?

BlossomHill Therapeutics, Inc. (BLSM) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is BlossomHill Therapeutics, Inc.'s market capitalisation and where is it listed?

BlossomHill Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 555,60M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is BLSM valued in terms of P/E ratio and EPS?

BLSM trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does BlossomHill Therapeutics, Inc. pay a dividend?

BlossomHill Therapeutics, Inc. pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.